Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
5iu8 | 6DZ | Adenosine receptor A2a |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
5iu8 | 6DZ | Adenosine receptor A2a | / | 1.000 | |
5iub | CLR | Adenosine receptor A2a | / | 0.751 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.671 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.669 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.665 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.646 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.642 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.641 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.636 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.635 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.629 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.579 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.570 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.539 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.531 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.517 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.512 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.494 | |
1a4i | NDP | C-1-tetrahydrofolate synthase, cytoplasmic | 1.5.1.5 | 0.477 | |
3uza | T4G | Adenosine receptor A2a | / | 0.471 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.470 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.465 | |
1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
1cqp | 803 | Integrin alpha-L | / | 0.459 | |
1xdd | AAY | Integrin alpha-L | / | 0.459 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.458 | |
4b4v | L34 | Bifunctional protein FolD | / | 0.457 | |
3qak | UKA | Adenosine receptor A2a | / | 0.457 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.454 | |
1osv | CHC | Bile acid receptor | / | 0.448 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.447 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.446 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.446 | |
4epl | JAI | Jasmonic acid-amido synthetase JAR1 | 6.3.2 | 0.445 | |
4jqh | 1MF | Alr2278 protein | / | 0.445 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
2gdz | NAD | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | 1.1.1.141 | 0.443 | |
4bc7 | FAD | Alkyldihydroxyacetonephosphate synthase, peroxisomal | 2.5.1.26 | 0.443 | |
1e6w | NAD | 3-hydroxyacyl-CoA dehydrogenase type-2 | 1.1.1.35 | 0.441 | |
1fmj | RTL | Retinol dehydratase | / | 0.441 | |
1jq5 | NAD | Glycerol dehydrogenase | 1.1.1.6 | 0.441 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.441 | |
1xuo | LA1 | Integrin alpha-L | / | 0.440 |